AdventHealth Orlando Infusion Center is a clinical research site located in Orlando, Florida, United States 32804.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
AdventHealth Orlando Infusion Center has participated in 9 clinical trials with 7 currently active.
Therapeutic areas: HER2-positive Breast Cancer, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Breast Cancer.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer, Stemline Therapeutics, Inc..
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
AdventHealth Orlando Infusion Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
AdventHealth Orlando Infusion Center has 9 clinical trials on record, with 7 currently active. Their work covers HER2-positive Breast Cancer, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Breast Cancer.
Yes — AdventHealth Orlando Infusion Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.